DEVELOPMENT OF THE PRINCIPLES TO CREATE A DIAGNOSTIC KIT TO ASSESS DRUG SENSITIVITY OF leukemIC cells
https://doi.org/10.51523/2708-6011.2011-8-3-19
Abstract
To assess the response of cells to antileukemic drugs in vitro in the concentration, similar to the therapeutic in blood, a diagnostic kit has been suggested to switch the panel of frozen-dried drugs that can help to compare the sensitivity of the patient`s leukemic cells to different preparations.
About the Authors
A. I. Svirnovskiy
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
T. F. Sergiyenko
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
V. V. Pasiukov
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
I. B. Taras
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
A. V. Bakun
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
A. S. Vasilevich
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
A. V. Stezhkin
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
N. A. Dreichuk
Republican Research Center for Hematology and Transfusiology
Belarus
Belarus
O. V. Aleinikova
Republican Research Center for Pediatric Oncology and Hematology
Belarus
Belarus
T. V. Shman
Republican Research Center for Pediatric Oncology and Hematology
Belarus
Belarus
L. A. Smirnova
Belarussian Medical Academy of Postgraduate Education
Belarus
Belarus
L. V. Kolbasko
Municipal Clinical Hospital No. 9
Belarus
Belarus
References
1. Flow cytometric chemosensitivity assay as a predictive tool of early clinical response in acute lymphoblastic leukemia / F. Galderisi [et al.] // Pediatric Blood Cancer. - 2009. - Vol. 53, № 4. - P. 543-550.
2. Relationship between in virto chemosensitivity assessed with MTT assay in clinical outcomes in 103 patients with acute leukemia / K. R. Jun. [et al.] // Korean J Lab Med. - 2007. - Vol. 27, № 2. - P. 89-95.
3. Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia / S. Yamada [et al.] // Leukemia. - 2001. - Vol. 15. - P. 1892-1897.
4. Prediction of clinical response to chemotherapy by in vitro chemosensitivity assay in acute leukemia / A. L. Dogan [et al.] // Turkish Journal of Cancer. - 2004. - Vol. 34, № 2. - P. 75-80.
5. Bosanquet, A. G. Individualized tumor response testing in leukemia and lymphoma / A. G. Bosanquet, P. Nygren, L. M. Weisenthal // In: G. J. Kaspers, eds. Innovate leukemia and lymphoma therapy. New York: Informa Healthcare. - 2008. - P. 23-43.
6. Лекарственная чувствительность лейкозных клеток ex vivo и прогнозирование ответа пациентов с ХЛЛ на терапию / А. И. Свирновский [и др.] // Здравоохранение. - 2010. - № 3. - С. 57-60.
7. Свирновский, А. И. Биологические свойства лейкозных клеток и клинический фенотип при хроническом лимфоцитарном лейкозе / А. И. Свирновский / Гематология и трансфузиология. - 2010. - № 1. - С. 25-32.
8. Анализ чувствительности лейкемических клеток к химиопрепаратам при остром лимфобластном лейкозе у детей по результатам МТТ-теста ex vivo / Т. А. Астрелина [и др.] // Гематология и трансфузиология. - 2002. - № 4. - С. 3-7.
9. Kaspers, G. J. L. Use of the differential staining cytotoxicity assay to predict chemosensitivity / G. J. L. Kaspers // Methods in molecular medicine. - 2005. - Vol. 110. - P. 49-57.
10. Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derovvatives / D. Bron [et al.] // Investigational New Drugs. - 2010. - Vol. 4, № 1. - P. 11-16.
11. Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy / M. Ragusa [et al.] // BMC Cancer. - 2010. - Vol. 10. - P. 377-391.
12. Variability in resposivenes to lovastin of the primitive CD34+ AML subfraction compared to normal CD34+ cells / S. D. P. W. M.de Joge Peeters [et al.] // Ann Hematol. - 2009. - Vol. 88. - P. 573-580.
13. Bosanquet, A. G. Laboratory tests of cytotoxic drug sensitivity / A. G. Bosanquet // Biomedical Scientist. - 2007. - Vol. 51. - P. 432-435.
14. Sargent, J. M. The use of the MTT assay to study drug resistance in fresh tumour samples / J. M. Sargent // Recent Results Cancer Res. - 2003. - Vol. 161. - P. 13-25.
15. Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukemia by an inhanced method of individualized tumor response testing / A. G. Bosanquet [et al.] // British Journal of Hematology. - 2009. - Vol. 146, № 4. - P. 384-395.
Review
For citations:
Svirnovskiy A.I., Sergiyenko T.F., Pasiukov V.V., Taras I.B., Bakun A.V., Vasilevich A.S., Stezhkin A.V., Dreichuk N.A., Aleinikova O.V., Shman T.V., Smirnova L.A., Kolbasko L.V. DEVELOPMENT OF THE PRINCIPLES TO CREATE A DIAGNOSTIC KIT TO ASSESS DRUG SENSITIVITY OF leukemIC cells. Health and Ecology Issues. 2011;(3):94-100. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-3-19
Views: 269
Email this article 